Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03706248 · ClinicalTrials.gov registry record
Paired Analysis of Sensitivity for Colorectal Cancer Using COLVERA : PASCAL
A clinical trial, sponsored by Clinical Genomics Pathology.
- Completed
- Registry status
- 65
- Enrollment target
NCT03706248 is a clinical trial that has completed, run by Clinical Genomics Pathology. The registered enrollment target is 65 participants.
The verdict
NCT03706248 has completed, sponsored by Clinical Genomics Pathology.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
To compare the sensitivity and specificity estimates of Colvera with that of a commercially available CEA test for detection of recurrent disease in subjects with colorectal cancer that have documented recurrence or no evidence of recurrence by CT.
Interventions
- OTHER Blood Draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2018-07-28 |
| Est. Completion | 2019-07-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03706248
The ClinicalTrials.gov registry entry for NCT03706248 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Clinical Genomics Pathology, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood Draw is the first listed.
NCT03706248 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03706248 about?
NCT03706248 is a clinical study titled "Paired Analysis of Sensitivity for Colorectal Cancer Using COLVERA : PASCAL". To compare the sensitivity and specificity estimates of Colvera with that of a commercially available CEA test for detection of recurrent disease in subjects with colorectal cancer that have documented recurrence or no evidence of recurrence by CT.
What is the current status of trial NCT03706248?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2018-07-28. Estimated completion is 2019-07-15.
What interventions are being tested in trial NCT03706248?
The interventions under investigation include: Blood Draw (OTHER).
Who is sponsoring clinical trial NCT03706248?
This trial is sponsored by Clinical Genomics Pathology, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.